Botanical species · safety record

Clivia miniata

The EFSA Compendium of Botanicals holds 26 constituent measurements and 1 adverse-effect record for Clivia miniata. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Clivia miniata (Lindl.) Bosse

26Constituent measurements

1Safety records

4Cited sources

0Licensed products (Canada)

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

Plant parts

Preparations

Effect types

Target tissues

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Indole alkaloids	Unspecified	—	—	Unspecified	Resolve DOI
Lectins	Bulb / clove	Solvent extraction	—	Gel electrophoresis	Resolve DOI
Alkaloids	Roots and other underground parts	—	0.07 Percent	Unspecified	No resolvable identifier
Biochanin-a	Roots and other underground parts	Solvent extraction	—	HPLC with standard detection methods	No resolvable identifier
Biochanin-a	Leaves	Solvent extraction	≤ 9.2 Nanogram/gram	HPLC with standard detection methods	No resolvable identifier
Daidzein	Roots and other underground parts	Solvent extraction	—	HPLC with standard detection methods	No resolvable identifier
Daidzein	Leaves	Solvent extraction	≤ 21.8 Nanogram/gram	HPLC with standard detection methods	No resolvable identifier
Daidzin	Leaves	Solvent extraction	—	HPLC with standard detection methods	No resolvable identifier
Formononetin	Roots and other underground parts	Solvent extraction	23.4 Nanogram/gram	HPLC with standard detection methods	No resolvable identifier
Formononetin	Leaves	Solvent extraction	≤ 31 Nanogram/gram	HPLC with standard detection methods	No resolvable identifier
Formononetin	Leaves	Solvent extraction	≥ 8.7 Nanogram/gram	HPLC with standard detection methods	No resolvable identifier
Genistein	Roots and other underground parts	Solvent extraction	—	HPLC with standard detection methods	No resolvable identifier
Genistein	Leaves	Solvent extraction	≥ 23.8 Nanogram/gram	HPLC with standard detection methods	No resolvable identifier
Genistein	Leaves	Solvent extraction	≤ 30.5 Nanogram/gram	HPLC with standard detection methods	No resolvable identifier
Genistin	Leaves	Solvent extraction	≤ 117.5 Nanogram/gram	HPLC with standard detection methods	No resolvable identifier
Genistin	Roots and other underground parts	Solvent extraction	399.7 Nanogram/gram	HPLC with standard detection methods	No resolvable identifier
Glycitin	Roots and other underground parts	Solvent extraction	—	HPLC with standard detection methods	No resolvable identifier
Glycitin	Leaves	Solvent extraction	≤ 122.5 Nanogram/gram	HPLC with standard detection methods	No resolvable identifier
Isoflavones	Roots and other underground parts	Solvent extraction	324.8 Nanogram/gram	HPLC with standard detection methods	No resolvable identifier
Lycorine	Roots and other underground parts	—	0.53 Percent	Unspecified	No resolvable identifier
Ononin	Leaves	Solvent extraction	≥ 59 Nanogram/gram	HPLC with standard detection methods	No resolvable identifier
Ononin	Leaves	Solvent extraction	≤ 80.1 Nanogram/gram	HPLC with standard detection methods	No resolvable identifier
Puerarin	Leaves	Solvent extraction	18.7 Nanogram/gram	HPLC with standard detection methods	No resolvable identifier
Puerarin	Roots and other underground parts	Solvent extraction	27.2 Nanogram/gram	HPLC with standard detection methods	No resolvable identifier
Sissotrin	Roots and other underground parts	Solvent extraction	—	HPLC with standard detection methods	No resolvable identifier
Sissotrin	Leaves	Solvent extraction	43.4 Nanogram/gram	HPLC with standard detection methods	No resolvable identifier

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

Effect	Target tissue	Plant part	Preparation	Test organism	Test type	Source
Neurotoxicity	Neurologic: central nervous system	—	—	—	Not reported	Resolve DOI

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

VANDAMME, EJM., GOLDSTEIN, IJ., PEUMANS, WJ. A COMPARATIVE-STUDY OF MANNOSE-BINDING LECTINS FROM THE AMARYLLIDACEAE AND ALLIACEAE . Phytochemistry, 1991, vol. 30, no. 2, p. 509-514. DOI
Miksatkova, Petra., Lankova, Petra., Huml, Lukas., Lapcik, Oldrich. Isoflavonoids in the Amaryllidaceae family. Natural product research, 2014, vol. 28, no. 10, p. 690-697.
Nair, Jerald J., van Staden, Johannes. Pharmacological and toxicological insights to the South African Amaryllidaceae . Food and chemical toxicology, 2013, vol. 62, p. 262-275. DOI
Briggs, Carol K., Highet, Patricia F., Highet, R. J., Wildman, W. C. Alkaloids of the Amaryllidaceae. VII. Alkaloids containing the hemiacetal or lactone group. Journal of the american chemical society, 1956, vol. 78, p. 2899-2904.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature